Affective Processing in Depression and Epilepsy

NCT ID: NCT00855725

Last Updated: 2009-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine whether there are unique markers on neuroimaging that are associated with depression in epilepsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Symptoms of depression is commonly seen in patients with epilepsy. There are similarities and differences between depressive symptoms in epilepsy when compared with primary depression. Through the use of fMRI (Functional MRI), we hope to determine whether there are unique markers on neuroimaging that are associated with depression in epilepsy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy Depression Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fMRI

Subjects will undergo MRI scanning to gather data about cognetive functions.

Intervention Type OTHER

Hamilton Depression Rating Scale

Investigator will evalute the subject during a one on one interview for depression using the Hamilton Depression Rating Scale.

Intervention Type OTHER

Beck's Depressive Inventory

Subjects will complete self assessment to evaluate their level of depression.

Intervention Type OTHER

Interictal Dysphoric Disorder Inventory (IDDI)

Subject will complete self assessment to determine if there have been any changes in mood, emotions and or feelings from time to time.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adults of 18 years of age or older.


* Subject is at least 18 years of age
* Subject has confirmed temporal lobe epilepsy (TLE)


* Subject is at least 18 years of age
* Subject scores between 12 and 18 on Hamilton Depression Rating Scale


* Subject has confirmed temporal lobe epilepsy (TLE)
* Subject scores between 12 and 18 on Hamilton Depression Rating Scale

Exclusion Criteria

* Subject has no history of affective disorders
* Subject scores higher than 5 on Hamilton Depression Rating Scale
* Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
* Subject is pregnant
* Subject is unable to undergo a MRI

Epilepsy Only Group


* Subject has a history of depression
* Subject scores higher then 5 on Hamilton Depression Rating Scale
* Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
* Subject is pregnant
* Subject is unable to undergo a MRI

Depression Only Group


* Subject scores higher than 18 on Hamilton Depression Rating Scale
* Subject is currently being medicated for depression
* Subject has history of major depression or dysthymia
* Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
* Subject is pregnant
* Subject is unable to undergo a MRI

Depression and Epilepsy Group


* Subject has history of major depression or dysthymia
* Subject is currently on medication for depression
* Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder, anxiety disorder, or any other serious medical or neurological disorder
* Subject is pregnant
* Subject is unable to undergo a MRI
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vice Chairman, Department of Neurology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alan Ettinger, M.D.

Role: PRINCIPAL_INVESTIGATOR

Northwell Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

North Shore LIJ Health System

Manhasset, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-128

Identifier Type: -

Identifier Source: secondary_id

GCRC 0246

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Decoding Chronic Pain With fMRI
NCT01766973 COMPLETED
PET Neuroimaging of [11C]Mirtazapine
NCT00288782 COMPLETED PHASE4